Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: Results of Phase I trials

Journal of Nuclear Medicine

Volumn 33, Issue 6, 1992, Pages 1099-1112

  Breitz, H B ^a   Weiden, P L ^a   Vanderheyden, J L ^a   Appelbaum, J W ^a   Bjorn, M J ^a   Fer, M F ^a   Wolf, S B ^a   Ratliff, B A ^a   Seiler, C A ^a   Foisie, D C ^a   Fisher, D R ^a   Schroff, R W ^a   Fritzberg, A R ^a   Abrams, P G ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; RHENIUM 186;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; BLOOD CELL COUNT; BONE MARROW SUPPRESSION; CARCINOMA; CLINICAL ARTICLE; DOSIMETRY; FACE EDEMA; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTENSION; IMMUNOREACTIVITY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER DYSFUNCTION; MALE; NUCLEAR MEDICINE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; RADIOIMMUNOTHERAPY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMAL; ANTIBODIES, MONOCLONAL; DRUG EVALUATION; FEMALE; HUMAN; MALE; MICE; MIDDLE AGE; NEOPLASMS; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RHENIUM;

EID: 0026634188     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)